John R Neefe

Title: John R Neefe: Innovator in Human Papilloma Virus Treatment

Introduction

John R Neefe is a notable inventor based in Devon, PA (US), recognized for his contributions to medical treatments, particularly in the field of human papilloma virus (HPV). With a total of 3 patents, Neefe has made significant strides in developing methods to combat HPV infections.

Latest Patents

Neefe's latest patents focus on innovative methods for treating warts and HPV infections. One of his key patents discloses a method of treating a wart in a subject by administering a composition that includes a heat shock protein or an immunostimulatory fragment, along with a protein of a human papilloma virus or an antigenic fragment. Additionally, he has developed a method for treating a human papilloma virus infection in subjects infected or suspected of being infected with different types of HPV. This method involves administering a composition containing a heat shock protein and a protein of a different type of human papilloma virus.

Career Highlights

Throughout his career, John R Neefe has worked with several prominent companies in the biopharmaceutical sector. Notably, he has been associated with Nventa Biopharmaceuticals Corporation and Stressgen Biotechnologies Corporation, where he contributed to the advancement of biotechnological solutions.

Collaborations

Neefe has collaborated with esteemed colleagues in his field, including Stephen E Goldstone and Mark T Winnett. These collaborations have further enriched his work and expanded the impact of his innovations.

Conclusion

John R Neefe's work in developing treatments for human papilloma virus showcases his dedication to medical innovation. His patents reflect a commitment to improving health outcomes for individuals affected by HPV.